Loading viewer...
report
Format: PDF report
This report details the development and clinical evaluation of BIO89-100, a novel FGF21 analog for treating NASH and severe hypertriglyceridemia.
presentation
report
Uniti Group
report
Basware Corporation
report
Maybank
report
OutSystems